Question 1

What are the potential side effects of NCX 470 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension clinical trial (NCT03657797). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial help me manage my eye pressure more effectively?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension clinical trial (NCT03657797). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the study process involve, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension clinical trial (NCT03657797). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension clinical trial (NCT03657797). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension clinical trial (NCT03657797). Contact the study team or your healthcare provider for specific answers.

What this study is about